Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02261571|
Recruitment Status : Unknown
Verified October 2014 by Hyun jung, Jung, The Comprehensive and Integrative Medicine Institute of South Korea.
Recruitment status was: Not yet recruiting
First Posted : October 10, 2014
Last Update Posted : October 10, 2014
Most cancer patients experience multiple symptoms related to chemotherapy and use CAM (complementary and alternative medicine) as an adjunct to conventional treatment. Moxibustion is traditional Korean medical therapeutic method and uses the heat generated by burning herbal preparations containing Artemisia vulgaris to stimulated acupoint.
Herein, the investigators propose an open-label pilot study investigating the effectiveness of moxibustion stimulation at abdominal acupoint on quality of life in cancer patients under chemotherapy.
|Condition or disease||Intervention/treatment||Phase|
|Cancer||Other: Moxibustion||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Supportive Care|
|Official Title:||A Pilot Study to Estimate the Efficacy of Moxibustion Stimulation at Abdominal Acupoints on Quality of Life in Cancer Patients Under Chemotherapy|
|Study Start Date :||October 2014|
|Estimated Primary Completion Date :||September 2015|
|Estimated Study Completion Date :||September 2015|
A series of moxibustion sessions within six weeks from baseline with adjuvant chemotherapy.
In the moxibustion treatment group, 3 moxibustion, 3 acupoints(CV12, CV8, CV54) will be heated with indirected moxibustion.
The moxibustion will be removed when the patient feel hotness and require remove them
No Intervention: Waiting
Participants who will be allocated to waitlist will receive no moxibustion treatments throughout the 6 weeks while receiving adjuvant chemotherapy
- functional Assessment of Cancer Therapy: General (FACT-G) [ Time Frame: change from baseline to 6 weeks ]
- Body mass index [ Time Frame: change from baseline to 6 weeks ]
- immune function [ Time Frame: change from baseline to 6 weeks ]lymphocyte panel(CD3,4,8,19,26), WBC, Differential count
- M.D, Anderson symptom Inventory (MDASI) [ Time Frame: change from baseline to 6 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02261571
|Contact: Hyun Jung Jung, KMD, Ph. Dfirstname.lastname@example.org|
|Korea, Republic of|
|Deagu Hanny University Medical center||Not yet recruiting|
|Deagu, Korea, Republic of, 704-123|
|Contact: Hyun Jung Jung, KMD, Ph. D|
|Sub-Investigator: Kyung Soon Kim, KMD|